首页> 美国卫生研究院文献>Pharmaceutics >Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals—The Case of Simvastatin
【2h】

Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals—The Case of Simvastatin

机译:介孔二氧化硅粒径在稳定非晶态药物中的重要性-以辛伐他汀为例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this paper, the role of mesoporous silica (MS) particle size in the stabilization of amorphous simvastatin (SVT) is revealed. For inhibiting recrystallization of the supercooled drug, the two MS materials (Syloid XDP 3050 and Syloid 244 FP) were employed. The crystallization tendency of SVT alone and in mixture with the MS materials was investigated by Differential Scanning Calorimetry (DSC) and Broadband Dielectric Spectroscopy (BDS). Neither confinement of the SVT molecules inside the MS pores nor molecular interactions between functional groups of the SVT molecules and the surface of the stabilizing excipient could explain the observed stabilization effect. The stabilization effect might be correlated with diffusion length of the SVT molecules in the MS materials that depended on the particle size. Moreover, MS materials possessing different particle sizes could offer free spaces with different sizes, which might influence crystal growth of SVT. All of these factors must be considered when mesoporous materials are used for stabilizing pharmaceutical glasses.
机译:本文揭示了介孔二氧化硅(MS)粒径在稳定无定形辛伐他汀(SVT)中的作用。为了抑制过冷药物的重结晶,使用了两种MS材料(Syloid XDP 3050和Syloid 244 FP)。通过差示扫描量热法(DSC)和宽带介电谱(BDS)研究了SVT单独以及与MS材料混合时的结晶趋势。将SVT分子限制在MS孔内,或者SVT分子的官能团与稳定赋形剂表面之间的分子相互作用都不能解释观察到的稳定作用。稳定作用可能与SVT分子在MS材料中的扩散长度有关,取决于颗粒大小。此外,具有不同粒径的MS材料可以提供具有不同尺寸的自由空间,这可能会影响SVT的晶体生长。当使用介孔材料稳定药物玻璃时,必须考虑所有这些因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号